Future Health ESG Corp.
FHLTU · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $186 | $98 | $103 | $240 |
| SG&A Expenses | $186 | $98 | $103 | $240 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $28 | $7 | $7 | $9 |
| Operating Expenses | $215 | $105 | $110 | $248 |
| Operating Income | -$215 | -$105 | -$110 | -$248 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $191 | $215 | $198 | $181 |
| Pre-Tax Income | -$24 | $110 | $88 | -$68 |
| Tax Expense | $34 | $44 | $40 | $36 |
| Net Income | -$58 | $66 | $47 | -$104 |
| % Margin | – | – | – | – |
| EPS | -0.009 | 0.01 | 0.007 | -0.016 |
| % Growth | -188.1% | 40.3% | 145.9% | – |
| EPS Diluted | -0.009 | 0.01 | 0.007 | -0.016 |
| Weighted Avg Shares Out | 6,589 | 6,592 | 6,592 | 6,592 |
| Weighted Avg Shares Out Dil | 6,589 | 6,592 | 6,592 | 6,592 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $3 | $3 | $6 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $215 | $105 | -$195 | -$175 |
| EBITDA | -$0 | $0 | -$110 | -$248 |
| % Margin | – | – | – | – |